Your Feed

Filter by
See content from
Back to the latest
Avatar
cobaltSheep
Multiple Myeloma Discussion • December 31, 2023
Lingering Nausea & Appetite After SCT: Tips?
AI-generated title
I have a friend who had a SCT in Oct. She is still having issues with nausea and lack of appetite. She has reached out to her healthcare team but still having issues. I had a SCT 3/21 but did not have those issues, so I am asking if anyone else had those issues and how did you resolve them?
Thumbnail for Optimizing BTK Inhibitor Treatment in CLL: Dose Reduction Impact | Kerry Rogers, MD | ASH 2023
Playlist: ASH 2023

Optimizing BTK Inhibitor Treatment in CLL: Dose Reduction Impact | Kerry Rogers, MD | ASH 2023

Video details & playlist
Avatar
Julia
Multiple Myeloma Discussion • December 29, 2023
Experiences Adding Darzalex for Rising MRD?
AI-generated title
Just received my MRD results. First year after transplant I had +5. After year 2 on maintenance therapy-Revlimid 10mg 28 day cycle, I was +14. Dr. Recommending to add Darzalex injection therapy. Bone marrow biopsy in 6 months. Anyone tried this? Results?
Avatar
Dawnie
Multiple Myeloma Discussion • December 28, 2023
Shaky Hands on Treatment? Anyone Else?
AI-generated title
I am currently on Darzalex Faspro, Pomalyst and Dex for treatment after a stem cell transplant that was not successful. I am noticing for a quite a while now that my hands get kind of shaky and my handwriting on some days is awful and it used to be beautiful, and some days it's hard to even apply my makeup smoothly. I know it's a silly question, but has anyone else noticed this type of hand symptom from any of these possible drugs? I'm thinking maybe the Dex?
Thumbnail for Mezigdomide Plus Dexamethasone in RRMM: CC-92480-MM-002 Trial Results | Paul Richardson, MD | ASH 2023
Playlist: ASH 2023

Mezigdomide Plus Dexamethasone in RRMM: CC-92480-MM-002 Trial Results | Paul Richardson, MD | ASH 2023

Video details & playlist
Thumbnail for Outcomes of Triple Class Refractory Multiple Myeloma Patients | James Berenson, MD | ASH 2023
Playlist: ASH 2023

Outcomes of Triple Class Refractory Multiple Myeloma Patients | James Berenson, MD | ASH 2023

Video details & playlist
Thumbnail for The TEDDi-R Regimen for DLBCL with CNS Involvement | Mark Roschewski, MD | ASH 2023
Playlist: ASH 2023

The TEDDi-R Regimen for DLBCL with CNS Involvement | Mark Roschewski, MD | ASH 2023

Video details & playlist
Thumbnail for Second Generation CLL Treatment: Zanubrutinib + Sonrotoclax | Constantine Tam, MD, MBBS | ASH 2023
Playlist: ASH 2023

Second Generation CLL Treatment: Zanubrutinib + Sonrotoclax | Constantine Tam, MD, MBBS | ASH 2023

Video details & playlist
Avatar
goldmine848
Multiple Myeloma Discussion • December 28, 2023
DKd + Pom: Tips and What to Expect?
AI-generated title
Looking for anyone who has direct experience with the DKd ,plus Pom treatment regimen. Particularly interested in tips regarding side effects and what to expect in general. Thanks.
Thumbnail for Undetectable Circulating Tumor Cells in Myeloma Patients | Juan-José Garcés, PhD | ASH 2023
Playlist: ASH 2023

Undetectable Circulating Tumor Cells in Myeloma Patients | Juan-José Garcés, PhD | ASH 2023

Video details & playlist
Thumbnail for Optimizing CLL Treatment: BTK Resistance and Dual Therapy | Kerry Rogers, MD | ASH 2023
Playlist: ASH 2023

Optimizing CLL Treatment: BTK Resistance and Dual Therapy | Kerry Rogers, MD | ASH 2023

Video details & playlist
Thumbnail for Assessing Lenalidomide with Patients Progressing on JAK Inhibitors | James Berenson, MD | ASH 2023
Playlist: ASH 2023

Assessing Lenalidomide with Patients Progressing on JAK Inhibitors | James Berenson, MD | ASH 2023

Video details & playlist